Compare GWW & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GWW | BSX |
|---|---|---|
| Founded | 1927 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.0B | 68.0B |
| IPO Year | 1994 | 2010 |
| Metric | GWW | BSX |
|---|---|---|
| Price | $1,472.30 | $44.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 31 |
| Target Price | ★ $1,435.14 | $49.60 |
| AVG Volume (30 Days) | 279.2K | ★ 18.4M |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | ★ 0.68% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | ★ 36.08 | 1.92 |
| Revenue | N/A | ★ $9,076,000,000.00 |
| Revenue This Year | $10.78 | $4.46 |
| Revenue Next Year | $7.62 | N/A |
| P/E Ratio | $40.98 | ★ $23.30 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $906.52 | $39.57 |
| 52 Week High | $1,521.41 | $105.65 |
| Indicator | GWW | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 70.71 | 51.86 |
| Support Level | $1,318.65 | $41.92 |
| Resistance Level | N/A | $46.09 |
| Average True Range (ATR) | 34.45 | 1.69 |
| MACD | 9.68 | 0.06 |
| Stochastic Oscillator | 76.24 | 68.65 |
Founded in 1927, W.W. Grainger originally distributed various motors via a mail-order catalog. Over the course of the 20th century, the firm expanded into new industrial product categories and launched its first digital catalog in 1995. Today, the company organizes itself into two segments focused on different customer bases. Its larger segment, high-touch solutions, offers a vast array of maintenance, repair, and operations, or MRO, supplies and bespoke inventory management services to larger businesses. Its smaller segment, endless assortment, operates two online platforms, Zoro and MonotaRO, that offer comprehensive catalogs of MRO supplies to smaller businesses. Grainger has operations throughout the world but primarily generates sales within the US.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.